Health Care

Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment

Leqembi's rollout has been slowed by bottlenecks related to reimbursement uncertainties, diagnostic test requirements and regular brain scans, among others.

adminadmin
Sep 8, 2024 - 22:00
 0  9
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Leqembi's rollout has been slowed by bottlenecks related to reimbursement uncertainties, diagnostic test requirements and regular brain scans, among others.
Read More

Tags:

Previous Article

JPMorgan downgrades its opinion on China, but still likes these individual stocks

Next Article

As consumers trade down to cheaper private label brands, these stocks could head up

admin
admin

Related Posts

Plant-based meat substitutes may be healthier for the heart than real meat

Plant-based meat substitutes may be healthier for the h...

admin Jun 26, 2024  0  7

Apple won't launch a smart ring, says Oura CEO: 'It's hard to do'

Apple won't launch a smart ring, says Oura CEO: 'It's h...

admin Nov 13, 2024  0  9

Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market

Healthy Returns: Eli Lilly gains momentum against Novo ...

admin Aug 15, 2024  0  8